{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02292628",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CMMAd/InFe/2011"
      },
      "Organization": {
        "OrgFullName": "Andalusian Network for Design and Translation of Advanced Therapies",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence",
      "OfficialTitle": "Study Phase I/II, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence"
    },
    "StatusModule": {
      "StatusVerifiedDate": "April 2018",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 2013"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 2017",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "September 2017",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "November 6, 2014",
      "StudyFirstSubmitQCDate": "November 12, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "November 17, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "April 16, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 17, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Iniciativa Andaluza en Terapias Avanzadas",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This is a clinical trial phase I/II, double blind, randomized to compare in two groups of patients to evaluate the safety and efficacy of the autologous mesenchymal stem cells from the adipose tissue (CMMAd) in the treatment of the faecal incontinence.",
      "DetailedDescription": "In the phase of recruitment, of 20 months of duration, there will be included 16 participants who will be randomized to one of the groups of intervention (8 patients group CMMAd / 8 patients group placebo). The phase of follow-up of every patient will be 12 months, though, provided that these patients are seen regularly in the study sites of the study, once concluded his follow-up will be continued to be able to obtain safety information and efficacy to 24 months."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Faecal Incontinence"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Triple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Investigator"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "16",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Autologous mesenchymal stem cells from the adipose tissue in an unique intralesional infusion with a dose of 40 million cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Infusion of mesenchymal stem cells from adipose tissue"
              ]
            }
          },
          {
            "ArmGroupLabel": "Ringer lactate solution",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Ringer lactate solution",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Infusion of placebo"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "Infusion of mesenchymal stem cells from adipose tissue",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal stem cells"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "Infusion of placebo",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Ringer lactate solution"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Number of Serious Adverse Events",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Changes in the faecal incontinence diary",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Anorectal manometry",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Jorge-Wexner Score",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Faecal Incontinence Quality of Life",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMales or females in the age group of 18-80 yrs.\nA unique internal sphincter defect and / or external (no more than 100 º), at any level of the anal canal, of any cause (except those described in the exclusion criteria).\nSeverity of faecal incontinence of 12 or more in the Wexner Score and / or at least six episodes of faecal incontinence for a period of 28 days.\nDuration of faecal incontinence of at least two years prior to inclusion.\nPatients who are able to understand the requirements of the study, and willing to provide voluntary written informed consent.\n\nExclusion Criteria:\n\nMore of an external sphincter defect and / or at any level of internal anal canal.\nHave received treatment to faecal failure with bulking agents, neuromodulation or surgery.\nCurrent anorectal tumors.\nCurrent anal fissures.\nAnorectal stenosis\nChronic pelvic or anorectal pain.\nPregnant or 6 months postpartum.\nMedical history of infection with Human Immunodeficiency Virus (HIV) or any severe immunocompromised state or therapy immunosuppressive.\nMalignancies in remission for less than a year before the study. An exception to the basocellular carcinoma (BCC) in \"remission\" for less than a year.\nBleeding diathesis or current anticoagulant therapy.\nChemotherapy during the 6 months preceding the study.\nPrevious radiation with evidence of radiation injury in the treated area.\nParticipation in any other clinical study during the 3 months preceding the pre-study visit.\nPatients with other serious disorders.\nPatients with uncontrolled inflammatory disease or taking drugs prohibited in the protocol or active perianal disease.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Fernando de la Portilla, Dr.",
            "OverallOfficialAffiliation": "Hospital U. Virgen del Rocio",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Santiago Mera, Dr.",
            "OverallOfficialAffiliation": "Hospital Regional U de Málaga",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "H. Juan Ramón Jiménez",
            "LocationCity": "Huelva",
            "LocationZip": "21005",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Fundación Jiménez Díaz",
            "LocationCity": "Madrid",
            "LocationZip": "28040",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Hospital Regional U de Málaga",
            "LocationCity": "Málaga",
            "LocationZip": "29010",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Hospital U Virgen del Rocio",
            "LocationCity": "Sevilla",
            "LocationZip": "41013",
            "LocationCountry": "Spain"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000005242",
            "ConditionMeshTerm": "Fecal Incontinence"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000012002",
            "ConditionAncestorTerm": "Rectal Diseases"
          },
          {
            "ConditionAncestorId": "D000007410",
            "ConditionAncestorTerm": "Intestinal Diseases"
          },
          {
            "ConditionAncestorId": "D000005767",
            "ConditionAncestorTerm": "Gastrointestinal Diseases"
          },
          {
            "ConditionAncestorId": "D000004066",
            "ConditionAncestorTerm": "Digestive System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M7533",
            "ConditionBrowseLeafName": "Fecal Incontinence",
            "ConditionBrowseLeafAsFound": "Faecal Incontinence",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M13996",
            "ConditionBrowseLeafName": "Rectal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9596",
            "ConditionBrowseLeafName": "Intestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8035",
            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6407",
            "ConditionBrowseLeafName": "Digestive System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M21013",
            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "PhSol",
            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}